XIFYRM J Code: J1737
Injection, meloxicam (azurity), 1 mg
Q4 2026 Medicare Payment Limit for J1737, effective October 1, 2026: $1.06 per HCPCS billing unit. CMS publishes none for Q3 2026. From CMS's final file.
Drug & Product Overview
About XIFYRM
Xifyrm is a medication aligned to the HCPCS J Code: J1737 for billing, pricing, and reimbursement purposes in the United States. This Non-Opioid Analgesic medication is administered via the intravenous route and manufactured by Azurity Pharmaceuticals Inc.
Manufacturers, reach out to us to add more information.
NDC Code Information
Based on publicly available CMS files. Showing 1 of 2 NDCs — log in for the full crosswalk.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 24338-0153-02 | Xifyrm | Azurity Pharmaceuticals, Inc. | 300 | 30 MG / 1 ML |
| •••••-••••-•• Log in to view | XIFYRM | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
XIFYRM Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →
Meloxicam 505(b)(2) Information:
| HCPCS Code | Manufacturer | Active Ingredient | HCPCS Description |
|---|---|---|---|
| J1737 | Azurity Pharmaceuticals Inc | Meloxicam | Injection, meloxicam (azurity), 1 mg |
| J1738 | Baudax Bio | Meloxicam | Injection, meloxicam, 1 mg |
XIFYRM CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure) |
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →
XIFYRM Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there a manufacturer-published XIFYRM billing and coding guide?
Is there an available XIFYRM patient assistance program?
Where can I find XIFYRM prescribing information?
Where can I find XIFYRM side effect information?
Does billing XIFYRM require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to XIFYRM.
